How Is Rising Obesity Driving the Semaglutide Market?
Semaglutide Market was valued at USD 31.58 Billion in 2025 and is expected to reach USD 75.44 Billion by 2033, growing at a CAGR of 11.5% from 2027 to 2033. Obesity prevalence is a major factor fueling market growth, as semaglutide has demonstrated clinically significant weight reduction in patients with obesity and overweight conditions. Semaglutide demand forecast emphasizes that increasing...
0 Kommentare 0 Geteilt 136 Ansichten 0 Bewertungen
Gesponsert